GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Sale Of Business

Celltrion (XKRX:068270) Sale Of Business : ₩2,500 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Sale Of Business?

Celltrion's sale of business for the three months ended in Sep. 2024 was ₩1,500 Mil. It means Celltrion gained ₩1,500 Mil from selling business. Celltrion's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was ₩2,500 Mil.

Compared with last quarter (₩0 Mil in Jun. 2024 ), Celltrion gained more money from selling business in Sep. 2024 (₩1,500 Mil).

Celltrion Sale Of Business Historical Data

The historical data trend for Celltrion's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Sale Of Business Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,748.09 8,793.40 11,862.80 26,039.54 377,188.91

Celltrion Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1,000.00 - 1,500.00

Celltrion Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,500 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celltrion Sale Of Business Related Terms

Thank you for viewing the detailed overview of Celltrion's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Celltrion Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Sale Of Business
Comparable Companies
XKRX:326030 XKRX:302440 XKRX:028300 XKRX:196170 XKRX:145020 XKRX:048410 XKRX:086900 XKRX:214450 XKRX:141080 XKRX:096530 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Website
http://www.celltrion.com
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion Headlines

No Headlines